Hydrobromides
TARGETMOL CHEMICALS INC Clobenpropit dihydrobromide
Also available in 1 mL, 1 mg, 5 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. Clobenpropit dihydrobromide is a potent antagonist and inverse agonist of histamine H3R (histamine H3LR,pEC50 of 8.07) Purity 99.48%
TARGETMOL CHEMICALS INC TC-E 5003 200MG
Also available in 1 mL, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. TC-E 5003 (NSC-30176) is a selective inhibitor of PRMT1 with IC50 of 1.5 uM. Purity 97.01%
Ambeed 2-BROMOMETHYL PYRIDINE HYDROB
2-(Bromomethyl)pyridine hydrobromide-5 gramsCAS No.: 31106-82-8Ambeed
Apexbio Technology LLC NAN-190 hydrobromide 115338-32-4 10mg
NAN-190 hydrobromide (CAS 115338-32-4) is a selective antagonist of the serotonin 5-HT1A receptor functioning by inhibiting receptor-mediated signal transduction pathways In receptor binding assays NAN-190 hydrobromide demonstrates high affinity for 5-HT1A receptors and modulates neurotransmitter release This compound is frequently employed in neurobiology and psychiatric disorder studies to investigate 5-HT1A-related mechanisms serving as a valuable tool for elucidating serotonergic signaling and its implications in neural function and pathology
Medchemexpress LLC Sulfone, bis((4-chloroacetylamino)phenyl). | 17328-16-4 | MFCD00028183 | 98.0% | 401.26 g/mol | C16H14Cl2N2O4S | 1 ML
TC-E 5003 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor supplied as a ready-to-use 10 mM solution in DMSO for research use in biochemical and cell-based assays. Handle and store according to laboratory safety and storage guidelines.
- Selective PRMT1 inhibitor with reported IC50 ≈ 1.5 μM.
- Supplied as a 10 mM solution in DMSO, 1 mL vial.
- Purity 98.0% by HPLC.
- Molecular weight 401.26 g/mol.
- Store solution at -80°C for long-term stability; short-term storage at -20°C.
Medchemexpress LLC Galanthamine hydrobromide | 1953-04-4 | MFCD00067672 | 99.9% | C17H22BrNO3 | 100 MG
Galanthamine hydrobromide is a selective, reversible, and competitive alkaloid acetylcholinesterase (AChE) inhibitor with an IC50 of 0.35 μM. It also acts as a potent allosteric potentiating ligand (APL) for human α3β4, α4β2, and α6β4 nicotinic receptors (nAChRs). This compound is developed for research related to Alzheimer's disease (AD).
- Selective, reversible, competitive AChE inhibitor
- Potent allosteric potentiating ligand for human nicotinic receptors
- Reduces cognitive deficits in APP23 mice
- Protects against Aβ toxicity in SH-SY5Y cells
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 50 MG
Halofuginone hydrobromide (RU-19110) is a Febrifugine derivative that acts as a competitive prolyl-tRNA synthetase inhibitor. It is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibiting TGF-β activity. This compound exhibits various biological effects, including anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis activities. It also functions as a potent pulmonary vasodilator.
- Competitive prolyl-tRNA synthetase inhibitor.
- Inhibits type-I collagen synthesis.
- Attenuates osteoarthritis by inhibiting TGF-β activity.
- Potent pulmonary vasodilator, activating Kv channels and blocking Ca2+ channels.
- Exhibits anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis effects.
- Decreases NRF2 protein levels in tumors.
- Partially reverses established pulmonary hypertension.